Cargando…
PRIM2 Promotes Cell Cycle and Tumor Progression in p53-Mutant Lung Cancer
SIMPLE SUMMARY: The mutation or inactivation of tumor suppressor genes is a key driving force during tumorigenesis, among which, p53 mutation is a common feature of human cancer. Therefore, exploring the potential role of p53 mutation in the occurrence and development of tumors is a powerful support...
Autores principales: | Wang, Taoyuan, Tang, Tiansheng, Jiang, Youguo, He, Tao, Qi, Luyu, Chang, Hongkai, Qiao, Yaya, Sun, Mingming, Shan, Changliang, Zhu, Xinyuan, Liu, Jianshi, Wang, Jiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320259/ https://www.ncbi.nlm.nih.gov/pubmed/35884433 http://dx.doi.org/10.3390/cancers14143370 |
Ejemplares similares
-
Decreased SLC27A5 Suppresses Lipid Synthesis and Tyrosine Metabolism to Activate the Cell Cycle in Hepatocellular Carcinoma
por: Wang, Jiyan, et al.
Publicado: (2022) -
Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma
por: Wang, Jiyan, et al.
Publicado: (2022) -
The Potential Mechanisms of Cinobufotalin Treating Colon Adenocarcinoma by Network Pharmacology
por: Wang, Jiyan, et al.
Publicado: (2022) -
Prim
por: Pérez Galdós, Benito, 1843-1920
Publicado: (1943) -
Prim /
por: Pérez Galdós, Benito, 1843-1920
Publicado: (1980)